Provider review
Eden tirzepatide review
What Eden charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
We re-read Eden’s own pages on November 20, 2026. Its lowest all-in figure for compounded tirzepatide was $129 a month (every month). It states one price at every dose. Eden places =5 of 29 in our November 20, 2026 computed ranking, with 34 of the 40 points we measure for every program. FDA’s warning-letter index lists letter 728279 to Eden, with no close-out letter listed when we checked on November 20, 2026; letters are shown for information and do not change scores. Sections below that show July 2026 records are kept as dated history.
What is distinctive about this programme
The membership is half the bill
Eden's $99 semaglutide medication price is among the lowest published anywhere. The required $99 membership makes the real cost $198. For semaglutide, the membership is exactly half the total — the highest membership-to-medication ratio in our dataset.
Medication being flat at every dose is a genuine advantage, and it applies to both molecules.
The brand listings need checking against the manufacturer
Eden's brand entries are the most striking in our dataset. Brand Wegovy is listed at $1,695 medication plus $99 membership — $1,794 a month all-in. NovoCare sells the identical medicine direct for $149 to $349. Brand Zepbound appears at $1,399 plus $99, or $1,498, where LillyDirect sells it for $299 to $449.
These are disclosed prices rather than anything improper, and a patient is free to buy at them. But the difference is fourfold to twelvefold for the same product from the same manufacturer, and anyone considering a brand drug through this or any platform should price it at the manufacturer first.
Our source dataset also notes a correction here: a stored Eden brand-Zepbound figure of $299 was in fact LillyDirect's price rather than Eden's actual $1,399 — an error that would have made Eden look dramatically cheaper than it is, and a good illustration of why third-party figures need re-capture.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Semaglutide injectable | $198 | Reported |
| Tirzepatide injectable | $298 | Reported |
| Semaglutide brand injectable, FDA-approved | $1,794 | Reported |
Where it holds up
- Medication flat at every dose for both molecules
- Low published medication prices before the membership
- Membership structure is disclosed rather than hidden at checkout
Where it does not
- Membership is required for any medication and is half the semaglutide total
- Brand listings are at retail level, several times the manufacturer-direct price
- Total cost is mid-to-upper band despite low medication pricing
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Flat across covered doses |
| Lowest captured figure | $198/mo, month-to-month |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
Show this figure as a table
| Category | Points |
|---|---|
| Pricing transparency | 20 pts |
| Total annual cost | 20 pts |
| Clinical oversight | 15 pts |
| Pharmacy transparency | 15 pts |
| Support | 10 pts |
| Regulatory disclosure | 10 pts |
| Accessibility | 10 pts |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| Eden | month_to_month | compounded injectable | flat at all covered doses | $298 | — | $298 | Recurring | Reported | 2026-07-06 |
| Eden | month_to_month | compounded injectable | flat at all covered doses | $198 | — | $198 | Recurring | Reported | 2026-07-06 |
| Eden | month_to_month | brand injectable, FDA-approved | — | $1,794 | — | $1,794 | Recurring | Reported | 2026-07-06 |
How this sits against the market
Show this figure as a table
| Program | All-in monthly | Read |
|---|---|---|
| Collective | $85.58 | Read 2026-10-15 |
| WellMedr | $89 | Read 2026-10-15 |
| Mondae | $114 | Read 2026-10-15 |
| NexLife | $115 | Read 2026-11-06 |
| Embody | $119 | Read 2026-10-15 |
| NextMeds | $119 | Read 2026-10-15 |
| SnagRx | $119 | Read 2026-10-15 |
| yourEra | $123 | Read 2026-10-15 |
| NewMeMeds | $125 | Older record, 2026-09-20 |
| CoreAge Rx | $129 | Read 2026-10-15 |
| Eden Health | $129 | Read 2026-10-15 |
| SkinnyRx | $129 | Older record, 2026-08-27 |
| GobyMeds | $133 | Read 2026-10-15 |
| Telos RX | $139 | Read 2026-10-15 |
| Sprout Health | $149 | Read 2026-10-15 |
| Strut Health | $149 | Read 2026-10-15 |
| He & She MD | $159 | Read 2026-10-15 |
| Bodybuilding Health+ | $174.67 | Read 2026-10-15 |
| bmiMD | $179 | Older record, 2026-09-17 |
| IVIM Health | $192 | Read 2026-10-15 |
| Alloy | $199 | Read 2026-10-15 |
| TelePep | $214 | Read 2026-10-15 |
| Yucca Health | $225 | Older record, 2026-09-12 |
| Found | $239 | Read 2026-10-15 |
| Pallas Health | $239 | Read 2026-10-15 |
| ShedRx | $239 | Read 2026-10-15 |
| MyDrHank | $240 | Older record, 2026-09-17 |
| Enhance.MD | $280 | Read 2026-10-15 |
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | — |
| Shipping | no | — |
| Higher-dose surcharge | no | — |
| Initial consultation | no | — |
| Required laboratory work | no | — |
| Cancellation or restocking terms | no | — |
A dash means no figure held. How we grade evidence.
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Clinical model
Pharmacy and fulfilment
Billing, cancellation and support
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where Eden sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | — | Not answered Pending |
| Clinical oversight and care continuity | 20 pts | — | Not answered Pending |
| State access and operational reliability | 10 pts | — | Not answered Pending |
| Cancellation, billing and support transparency | 10 pts | — | Not answered Pending |
A dash means no figure held. How we grade evidence.
Questions readers actually ask
Is Eden the cheapest option?
We will not answer that until the all-in figures are captured for the whole comparison set. A cheapest claim needs a defined comparison group, a stated program type and a capture date, or it is just an adjective.
Is this review sponsored?
No. Reviews here are not sponsored, and no provider can buy a score, a placement or a review. Tirzepatide Ranked is affiliate-supported; the disclosure page explains how.
Is compounded tirzepatide the same as Zepbound?
No. Compounded preparations are not FDA-approved products and there is no generic tirzepatide. Approval of the brand product does not extend to a compounded preparation.
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Ro Body Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Mochi Health Tirzepatide ReviewProviders
- Flat-Rate vs Dose-Escalating GLP-1 PricingComparisons
- Flat-Rate Tirzepatide Pricing ComparedPillar / Money
Related coverage
Tirzepatide Ranked. “Eden Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/providers/eden/
Quote the capture date beside a figure, not the date you read this page. Why.
How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.